PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) — Revenue

Annual figures by fiscal year, from SEC filings.

2022: $989.0K2023: $557.7K2024: $617.1K2025: $336.1K$336.1K
2022Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$336.1K-45.5%
2024$617.1K+10.7%
2023$557.7K-43.6%
2022$989.0K